動物用寄生虫駆除剤市場の評価：寄生虫タイプ・動物タイプ・薬剤タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

世界の動物用寄生虫駆除剤の市場規模は、2023年の102億7,000万米ドルから、2024年から2031年の予測期間中は6.35%のCAGRで推移し、2031年には168億1,000万米ドルの規模に成長すると予測されています。

さまざまな内部寄生虫と外部寄生虫の脅威の増大と、治療ソリューションに対する意識の高まりが、世界の動物用寄生虫駆除剤市場を牽引しています。内部寄生虫も外部寄生虫も免疫系を弱め、病気を引き起こす可能性があります。そのため、寄生虫の脅威を確実に食い止めるために、さまざまな治療ソリューションに対する要求が高まっています。さらに、栄養価の高さから世界中のさまざまな地域で動物性食品の消費が増加していることも、動物用寄生虫駆除剤ソリューションの需要を高めています。牛肉や鶏肉などの非ベジタリアンの原料には、ビタミンB、タンパク質、亜鉛、マグネシウム、鉄が含まれており、これらは骨、軟骨、筋肉の強度を確保し、ホルモンや酵素の最適な生産を確保するために不可欠です。

さらに、企業買収の成功も市場の成長を後押ししています。買収によって企業は製品ポートフォリオを充実させ、幅広い顧客層に対応する能力を得ることで顧客基盤を拡大することができるからです。2021年11月、NEOGEN Corporationはさまざまなペット用医薬品の提供で知られるCAPInnoVet, Inc.の買収を発表しました。この買収によってNEOGENの能力は拡大し、寄生虫駆除剤市場に戦略的に参入することが可能になっています。

ペット飼育の増加が世界の動物用寄生虫駆除剤市場を牽引：

ペット飼育の増加は、世界の動物用寄生虫駆除剤市場の主要動向のひとつです。ペットの飼育が好まれる背景には、都市化の進展と核家族化の進行があります。Forbesの推計によると、米国におけるペットの飼育率は過去数年間で大幅に上昇しており、2024年には同国の世帯の約66％がペットを飼育するようになると推定されています。さまざまな治療ソリューションのアベイラビリティに対する認識の高まりに加え、コンパニオンアニマルを苦痛や病気から守りたいという思いが拡大していることが、ペットの飼い主にさまざまな動物用寄生虫駆除剤への出費を促しています。さらに、頻繁な投与が不要な治療法の開発も、その利便性からそうした治療法への嗜好が高まっており、市場の拡大を促進しています。

当レポートでは、世界の動物用寄生虫駆除剤の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の動物用寄生虫駆除剤市場の展望

• 市場規模・予測
• 寄生虫タイプ別
  • 内部寄生虫
  • 外部寄生虫
• 動物タイプ別
  • 食用動物
  • ペット
  • その他
• 薬剤タイプ別
  • 外部寄生虫駆除剤
  • 内部寄生虫駆除剤
  • エンデクトサイド
• エンドユーザー別
  • 動物農場
  • 動物病院・診療所
  • 在宅ケア
• 地域別
  • 北米
  • 南米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
• 企業別市場シェア

第5章 世界の動物用寄生虫駆除剤市場の展望：地域別

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 市場マッピング、2023年

• 寄生虫タイプ別
• 動物タイプ別
• 薬剤タイプ別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進因子
• 成長阻害因子 (課題・制約)

第9章 規制枠組みとイノベーション

• 特許情勢
• イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析（参入5社）

第11章 価格分析

第12章 ケーススタディ

第13章 主要プレーヤーの展望

• Bayer AG
• Zoetis Inc.
• Virbac Group
• Merck & Co., Inc.
• Ceva Sante Animale
• Boehringer Ingelheim International GmbH
• Elanco Animal Health Incorporated
• Vetoquinol Group
• PetIQ, LLC
• Bimeda Holdings Limited

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 2.Global Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 3.Global Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 4.Global Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 5.Global Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 6.Global Animal Parasite Treatment Market Share (%), By Region, 2017-2031F
• Figure 7.North America Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 8.North America Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 9.North America Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 10.North America Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 11.North America Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 12.North America Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
• Figure 13.United States Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 14.United States Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 15.United States Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 16.United States Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 17.United States Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 18.Canada Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 19.Canada Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 20.Canada Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 21.Canada Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 22.Canada Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 23.Mexico Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 24.Mexico Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 25.Mexico Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 26.Mexico Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 27.Mexico Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 28.Europe Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 29.Europe Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 30.Europe Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 31.Europe Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 32.Europe Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
• Figure 34.Germany Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 35.Germany Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 36.Germany Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 37.Germany Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 38.Germany Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 39.France Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 40.France Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 41.France Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 42.France Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 43.France Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 44.Italy Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 45.Italy Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 46.Italy Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 47.Italy Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 48.Italy Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 49.United Kingdom Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 50.United Kingdom Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 51.United Kingdom Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 52.United Kingdom Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 53.United Kingdom Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 54.Russia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 55.Russia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 56.Russia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 57.Russia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 58.Russia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 59.Netherlands Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 60.Netherlands Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 61.Netherlands Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 62.Netherlands Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 63.Netherlands Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 64.Spain Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 65.Spain Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 66.Spain Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 67.Spain Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 68.Spain Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 69.Turkey Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 70.Turkey Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 71.Turkey Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 72.Turkey Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 73.Turkey Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 74.Poland Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 75.Poland Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 76.Poland Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 77.Poland Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 78.Poland Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 79.South America Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 80.South America Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 81.South America Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 82.South America Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 83.South America Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 84.South America Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
• Figure 85.Brazil Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 86.Brazil Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 87.Brazil Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 88.Brazil Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 89.Brazil Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 90.Argentina Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 91.Argentina Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 92.Argentina Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 93.Argentina Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 94.Argentina Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 95.Asia-Pacific Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 96.Asia-Pacific Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 97.Asia-Pacific Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 98.Asia-Pacific Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 99.Asia-Pacific Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 100.Asia-Pacific Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
• Figure 101.India Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 102.India Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 103.India Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 104.India Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 105.India Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 106.China Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 107.China Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 108.China Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 109.China Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 110.China Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 111.Japan Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 112.Japan Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 113.Japan Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 114.Japan Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 115.Japan Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 116.Australia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 117.Australia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 118.Australia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 119.Australia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 120.Australia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 121.Vietnam Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 122.Vietnam Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 123.Vietnam Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 124.Vietnam Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 125.Vietnam Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 126.South Korea Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 127.South Korea Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 128.South Korea Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 129.South Korea Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 130.South Korea Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 131.Indonesia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 132.Indonesia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 133.Indonesia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 134.Indonesia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 135.Indonesia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 136.Philippines Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 137.Philippines Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 138.Philippines Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 139.Philippines Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 140.Philippines Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 141.Middle East & Africa Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 142.Middle East & Africa Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 143.Middle East & Africa Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 144.Middle East & Africa Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 145.Middle East & Africa Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 146.Middle East & Africa Animal Parasite Treatment Market Share (%), By Country, 2017-2031F
• Figure 147.Saudi Arabia Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 148.Saudi Arabia Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 149.Saudi Arabia Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 150.Saudi Arabia Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 151.Saudi Arabia Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 152.UAE Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 153.UAE Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 154.UAE Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 155.UAE Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 156.UAE Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 157.South Africa Animal Parasite Treatment Market, By Value, In USD Billion, 2017-2031F
• Figure 158.South Africa Animal Parasite Treatment Market Share (%), By Parasite Type, 2017-2031F
• Figure 159.South Africa Animal Parasite Treatment Market Share (%), By Animal Type, 2017-2031F
• Figure 160.South Africa Animal Parasite Treatment Market Share (%), By Treatment Type, 2017-2031F
• Figure 161.South Africa Animal Parasite Treatment Market Share (%), By End-user, 2017-2031F
• Figure 162.By Parasite Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163.By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164.By Treatment Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 166.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global animal parasite treatment market is projected to witness a CAGR of 6.35% during the forecast period 2024-2031, growing from USD 10.27 billion in 2023 to USD 16.81 billion in 2031F. The growth of the market is boosted by increasing consumption of animal derived products, rising popularity of pet adoption, and novel product launches and strategic collaborations.

The growing threat of various endoparasites and ectoparasites and increasing awareness about the treatment solutions drive the global animal parasite treatment market. Both internal and external parasites can weaken the immune system and cause diseases. Thus augmenting the requirement for different treatment solutions in order to ensure that the threat of parasites can be contained. Additionally, the growing consumption of animal-based products in various regions across the globe due to their high nutritional value is also increasing the demand for animal parasite treatment solutions. Non-vegetarian sources of foods such as beef and poultry include vitamin B, protein, zinc, magnesium, and iron, which are essential for ensuring the strength of bones, cartilage, and muscles and ensuring optimal production of hormones and enzymes.

Additionally, successful acquisitions are also bolstering the growth of the market as they allow companies to enhance their product portfolios and expand their customer base by gaining the ability to cater to a broad clientele. In November 2021, NEOGEN Corporation announced the acquisition of CAPInnoVet, Inc. a company known for providing various pet medications. The transaction expanded NEOGEN's capabilities and allowed them to enter the parasiticide market strategically.

Increasing Pet Adoption is Driving the Global Treatment Market for Animal Parasite

The rise of pet adoption is one of the major global animal parasite treatment market trends. The increasing preference for pet adoption can be attributed to increasing urbanization and the growing popularity of nuclear households. Pet parents have a vested interest in the health and well-being of their pets and ensure that the pets are provided with high-quality care and treatments. As per the estimates of Forbes, pet ownership in the United States has significantly increased over the past few years, and it is estimated that in 2024, approximately 66% of the households in the country own a pet. The growing awareness about the availability of various treatment solutions, coupled with the increasing preference for protecting companion animals from distress and diseases, is encouraging pet owners to spend on various animal parasite treatments. Additionally, the development of treatments that do not require frequent administration is also driving the expansion of the market as preference for such treatment options is increasing due to their convenience.

Introduction of Novel Products is Boosting Global Animal Parasite Treatment Market Demand

The growing emphasis on novel product development and launches is one of the major drivers of the market. In 2022, Vetoquinol launched Felpreva, the first spot-on parasiticide for felines that is capable of treating both external and internal parasite infections and infestations. The three-month spot-on parasiticide belongs to the bispyrazole chemical family and is effective against mites, fleas, and ticks as well as hookworms, lungworms, and roundworms. Meanwhile, in April 2024, Boehringer Ingelheim, one of the global leaders in animal health, announced that they are launching NexGard SPECTRA (milbemycin oxime and afoxolaner) in India. The new flavorful product launched by the company offers a broad spectrum of ecto- and endo-parasite control. This prescription-only product provides comprehensive protection with the help of a single monthly chewable, reducing the burden of treatment on animal owners and caretakers. Such developments and product launches increase the convenience of the care providers and allow companies to expand their customer base, boosting market growth.

North America Holds Significant Share in the Global Animal Parasite Treatment Market

The growth of the market in North America can be attributed to the strong presence of various key market players, the rise of pet adoption in the United States of America and Canada and increasing awareness about the various parasites and their treatments. The rising adoption of companion animals in the region can be attributed to the growing awareness about the various emotional benefits provided by them. The growing adoption of companion animals is supported by a rise in mental health conditions. The Progressive Animal Welfare Services (PAWS) estimates that one in five Canadians live with some form of mental illness. The Mental Health Commission of Canada estimates that approximately 23% of the country's population will be suffering from some mental illness by 2041. Several studies show a strong correlation between adopting a pet and improved mental health, with many emphasizing the mental health benefits of pet ownership. Pets, such as dogs and cats, provide companionship, unconditional love, and emotional support, which can alleviate feelings of loneliness, reduce stress, and boost mood.

Ectoparasiticides Are Expected to Witness Increase in Demand

The rising threat of ticks, mites, and fleas is boosting the demand for ectoparasiticides globally. Ectoparasites affect the skin of animals and can impact the production of animal products such as wool, silk, leather, and many others. The usage of ectoparasiticides is regulated by various governing bodies in different countries. In the United States, the use of ectoparasiticides is regulated by EPA (Environmental Protection Agency). Pour-ons are considered to be more effective against lice infestations (Haematopinus and Linognathus) as compared to equivalent compounds that are administered parenterally. This large consumption of animal-based products, including milk and meat, in various regions across the globe due to the various nutritional benefits offered by the food substances is augmenting the utilization of ectoparasiticides by cattle owners.

Future Market Scenario (2024-2031F)

As per the global animal parasite treatment market analysis, the market demand is expected to witness a significant increase owing to the rise in pet adoption, growing awareness about the various parasite treatment options and their preventive measures, increasing requirement for eco-friendly treatment options, and increasing collaborations to support novel product development. The requirement for treatment solutions that offer efficacy for longer periods of time is expected to rise as they aid in reducing the burden of treatment on livestock and pet owners. Additionally, due to the growing threat of climate change, a shift in preference for eco-friendly solutions is being witnessed across various industries, including animal parasite treatments. Thus, efforts towards the development of eco-friendly treatment solutions are increasing. Partnerships between various organizations are expected to boost such developments. For instance, the partnership between the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and Boehringer Ingelheim is expected to bolster the development of parasiticides.

Key Players Landscape and Outlook

Some of the leading players operating in the global animal parasite treatment market are Bayer AG, Zoetis Inc., Virbac Group, Merck & Co., Inc., and Elanco Animal Health Incorporated. The increasing efforts by various market players towards the development and launch of novel products are providing lucrative growth opportunities to the market. In 2023, Zoetis Inc. introduced the Valcor injectable, the first dual-active endectocide that will be available by prescription in the United States. The product received approval for use in replacement dairy heifers that are younger than twenty months and in beef cattle that are two months and older. The product has been designed to address 35 external and internal parasites. Valcor is also indicated for treating and controlling eyeworms and lungworms, among others, and contains two active ingredients that are responsible for causing parasite paralysis and death. Levamisole stimulates worm muscles, whereas Doramectin modulates chloride ion channel activities in the nervous system of orthopods and nematodes by inhibiting the electrical activity of nerve cells. The development of such products is expected to aid the market players in expanding their customer base and provide lucrative growth opportunities to the market in the forecast period.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Animal Parasite Treatment Market Outlook, 2017-2031F

• 4.1.Market Size & Forecast
  • 4.1.1.By Value
• 4.2.By Parasite Type
  • 4.2.1.Endoparasites
    • 4.2.1.1.Tapeworm
    • 4.2.1.2.Roundworm
    • 4.2.1.3.Flukes
    • 4.2.1.4.Protozoans of Vertebrates
    • 4.2.1.5.Others
  • 4.2.2.Ectoparasites
    • 4.2.2.1.Ticks
    • 4.2.2.2.Fleas
    • 4.2.2.3.Lice
    • 4.2.2.4.Mites
    • 4.2.2.5.Parasitic Flies
    • 4.2.2.6.Others
• 4.3.By Animal Type
  • 4.3.1.Food Producing Animals
    • 4.3.1.1.Poultry
    • 4.3.1.2.Cattle
    • 4.3.1.3.Sheep and Goats
    • 4.3.1.4.Swine
    • 4.3.1.5.Others
  • 4.3.2.Companion Animals
    • 4.3.2.1.Dogs
    • 4.3.2.2.Felines (Cat Family)
    • 4.3.2.3.Others
  • 4.3.3.Other Livestock
• 4.4.By Treatment Type
  • 4.4.1.Ectoparasiticides
    • 4.4.1.1.Pour On
    • 4.4.1.2.Spray
    • 4.4.1.3.Spot On
    • 4.4.1.4.Powder
    • 4.4.1.5.Collars
    • 4.4.1.6.Others
  • 4.4.2.Endoparasiticides
    • 4.4.2.1.Tablets
    • 4.4.2.2.Liquids
    • 4.4.2.3.Injectables
    • 4.4.2.4.Feed Additives
    • 4.4.2.5.Others
  • 4.4.3.Endectocides
• 4.5.By End-user
  • 4.5.1.Animal Farms
  • 4.5.2.Veterinary Hospitals and Clinics
  • 4.5.3.Homecare Settings
• 4.6.By Region
  • 4.6.1.North America
  • 4.6.2.South America
  • 4.6.3.Europe
  • 4.6.4.Asia-Pacific
  • 4.6.5.Middle East and Africa
• 4.7.By Company Market Share (%), 2023

5.Global Animal Parasite Treatment Market Outlook, By Region, 2017-2031F

• 5.1.North America*
  • 5.1.1.Market Size & Forecast
    • 5.1.1.1.By Value
  • 5.1.2.By Parasite Type
    • 5.1.2.1.Endoparasites
      • 5.1.2.1.1.Tapeworm
      • 5.1.2.1.2.Roundworm
      • 5.1.2.1.3.Flukes
      • 5.1.2.1.4.Protozoans of Vertebrates
      • 5.1.2.1.5.Others
    • 5.1.2.2.Ectoparasites
      • 5.1.2.2.1.Ticks
      • 5.1.2.2.2.Fleas
      • 5.1.2.2.3.Lice
      • 5.1.2.2.4.Mites
      • 5.1.2.2.5.Parasitic Flies
      • 5.1.2.2.6.Others
  • 5.1.3.By Animal Type
    • 5.1.3.1.Food Producing Animals
      • 5.1.3.1.1.Poultry
      • 5.1.3.1.2.Cattle
      • 5.1.3.1.3.Sheep and Goats
      • 5.1.3.1.4.Swine
      • 5.1.3.1.5.Others
    • 5.1.3.2.Companion Animals
      • 5.1.3.2.1.Dogs
      • 5.1.3.2.2.Felines (Cat Family)
      • 5.1.3.2.3.Others
    • 5.1.3.3.Other Livestock
  • 5.1.4.By Treatment Type
    • 5.1.4.1.Ectoparasiticides
      • 5.1.4.1.1.Pour On
      • 5.1.4.1.2.Spray
      • 5.1.4.1.3.Spot On
      • 5.1.4.1.4.Powder
      • 5.1.4.1.5.Collars
      • 5.1.4.1.6.Others
    • 5.1.4.2.Endoparasiticides
      • 5.1.4.2.1.Tablets
      • 5.1.4.2.2.Liquids
      • 5.1.4.2.3.Injectables
      • 5.1.4.2.4.Feed Additives
      • 5.1.4.2.5.Others
    • 5.1.4.3.Endectocides
  • 5.1.5.By End-user
    • 5.1.5.1.Animal Farms
    • 5.1.5.2.Veterinary Hospitals and Clinics
    • 5.1.5.3.Homecare Settings
  • 5.1.6.United States*
    • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
    • 5.1.6.2.By Parasite Type
      • 5.1.6.2.1.Endoparasites
        • 5.1.6.2.1.1.Tapeworm
        • 5.1.6.2.1.2.Roundworm
        • 5.1.6.2.1.3.Flukes
        • 5.1.6.2.1.4.Protozoans of Vertebrates
        • 5.1.6.2.1.5.Others
      • 5.1.6.2.2.Ectoparasites
        • 5.1.6.2.2.1.Ticks
        • 5.1.6.2.2.2.Fleas
        • 5.1.6.2.2.3.Lice
        • 5.1.6.2.2.4.Mites
        • 5.1.6.2.2.5.Parasitic Flies
        • 5.1.6.2.2.6.Others
    • 5.1.6.3.By Animal Type
      • 5.1.6.3.1.Food Producing Animals
        • 5.1.6.3.1.1.Poultry
        • 5.1.6.3.1.2.Cattle
        • 5.1.6.3.1.3.Sheep and Goats
        • 5.1.6.3.1.4.Swine
        • 5.1.6.3.1.5.Others
      • 5.1.6.3.2.Companion Animals
        • 5.1.6.3.2.1.Dogs
        • 5.1.6.3.2.2.Felines (Cat Family)
        • 5.1.6.3.2.3.Others
        • 5.1.6.3.2.4.Other Livestock
    • 5.1.6.4.By Treatment Type
      • 5.1.6.4.1.Ectoparasiticides
        • 5.1.6.4.1.1.Pour On
        • 5.1.6.4.1.2.Spray
        • 5.1.6.4.1.3.Spot On
        • 5.1.6.4.1.4.Powder
        • 5.1.6.4.1.5.Collars
        • 5.1.6.4.1.6.Others
      • 5.1.6.4.2.Endoparasiticides
        • 5.1.6.4.2.1.Tablets
        • 5.1.6.4.2.2.Liquids
        • 5.1.6.4.2.3.Injectables
        • 5.1.6.4.2.4.Feed Additives
        • 5.1.6.4.2.5.Others
      • 5.1.6.4.3.Endectocides
    • 5.1.6.5.By End-user
      • 5.1.6.5.1.Animal Farms
      • 5.1.6.5.2.Veterinary Hospitals and Clinics
      • 5.1.6.5.3.Homecare Settings
  • 5.1.7.Canada
  • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

• 5.2.Europe
  • 5.2.1.Germany
  • 5.2.2.France
  • 5.2.3.Italy
  • 5.2.4.United Kingdom
  • 5.2.5.Russia
  • 5.2.6.Netherlands
  • 5.2.7.Spain
  • 5.2.8.Turkey
  • 5.2.9.Poland
• 5.3.Asia-Pacific
  • 5.3.1.India
  • 5.3.2.China
  • 5.3.3.Japan
  • 5.3.4.Australia
  • 5.3.5.Vietnam
  • 5.3.6.South Korea
  • 5.3.7.Indonesia
  • 5.3.8.Philippines
• 5.4.South America
  • 5.4.1.Brazil
  • 5.4.2.Argentina
• 5.5.Middle East and Africa
  • 5.5.1.Saudi Arabia
  • 5.5.2.UAE
  • 5.5.3.South Africa

6.Market Mapping, 2023

• 6.1.By Parasite Type
• 6.2.By Animal Type
• 6.3.By Treatment Type
• 6.4.By End-user
• 6.5.By Region

7.Macro Environment and Industry Structure

• 7.1.Supply Demand Analysis
• 7.2.Import Export Analysis
• 7.3.Value Chain Analysis
• 7.4.PESTEL Analysis
  • 7.4.1.Political Factors
  • 7.4.2.Economic System
  • 7.4.3.Social Implications
  • 7.4.4.Technological Advancements
  • 7.4.5.Environmental Impacts
  • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5.Porter's Five Forces Analysis
  • 7.5.1.Supplier Power
  • 7.5.2.Buyer Power
  • 7.5.3.Substitution Threat
  • 7.5.4.Threat From New Entrant
  • 7.5.5.Competitive Rivalry

8.Market Dynamics

• 8.1.Growth Drivers
• 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

• 9.1.Patent Landscape
• 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

• 10.1.Competition Matrix of Top Five Market Leaders
• 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

• 13.1.Bayer AG
  • 13.1.1.Company Details
  • 13.1.2.Key Management Personnel
  • 13.1.3.Products and Services
  • 13.1.4.Financials (As reported)
  • 13.1.5.Key Market Focus and Geographical Presence
  • 13.1.6.Recent Developments
• 13.2.Zoetis Inc.
• 13.3.Virbac Group
• 13.4.Merck & Co., Inc.
• 13.5.Ceva Sante Animale
• 13.6.Boehringer Ingelheim International GmbH
• 13.7.Elanco Animal Health Incorporated
• 13.8.Vetoquinol Group
• 13.9.PetIQ, LLC
• 13.10.Bimeda Holdings Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer